In the BioHarmony Drug Report Database

"Preview" Icon

Idarubicin

Idamycin, Idamycin Pfs (idarubicin) is a small molecule pharmaceutical. Idarubicin was first approved as Idamycin on 1990-09-27. It is used to treat bcr-abl positive chronic myelogenous leukemia, breast neoplasms, myeloid leukemia acute, and precursor cell lymphoblastic leukemia-lymphoma in the USA.

 

Trade Name

 

Idamycin, Idamycin Pfs
 

Common Name

 

idarubicin
 

ChEMBL ID

 

CHEMBL1117
 

Indication

 

bcr-abl positive chronic myelogenous leukemia, breast neoplasms, myeloid leukemia acute, precursor cell lymphoblastic leukemia-lymphoma
 

Drug Class

 

Antineoplastic antibiotics (daunorubicin type)

Image (chem structure or protein)

Idarubicin structure rendering